Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2007 Oct 17;2007(4):CD000498.
doi: 10.1002/14651858.CD000498.pub2.

Intraventricular streptokinase after intraventricular hemorrhage in newborn infants

A Whitelaw  1 , D E Odd
Affiliations
Meta-Analysis

Intraventricular streptokinase after intraventricular hemorrhage in newborn infants

A Whitelaw et al. Cochrane Database Syst Rev. .

Abstract

Background: Hydrocephalus following intraventricular hemorrhage (IVH) is still one of the most serious complications of premature birth. Ventriculoperitoneal shunt surgery cannot be carried out early and permanent dependence on a shunt is associated with several serious complications. Streptokinase could be useful in the treatment of post-hemorrhagic hydrocephalus. This form of therapy is based on the hypothesis that multiple blood clots in the cerebrospinal fluid (CSF) are the initial cause of post-hemorrhagic ventricular dilatation and lysis of clots could reopen the pathways of circulation and re-absorption of CSF.

Objectives: To determine the effect of intraventricular streptokinase after intraventricular hemorrhage on the risk of permanent shunt dependence, neurodevelopmental disability or death in neonates at risk for, or actually developing post-hemorrhagic hydrocephalus (PHH).

Search strategy: Pediatric, Neurosurgical and General Medical Journals were handsearched from 1976 until October 2000, as well as the MEDLINE database (via PubMed) and the Cochrane Central Register of Controlled Trials (CENTRAL, The Cochrane Library) up to April 2007. Personal contacts were used.

Selection criteria: Randomized controlled trials and quasi-randomized controlled trials evaluating the use of injection of streptokinase into the CSF in infants having or at risk for post-hemorrhagic hydrocephalus.

Data collection and analysis: Details of patient selection, patient allocation and the interventions were extracted. The end-points examined were: ventriculoperitoneal shunt, death, meningitis, and secondary hemorrhage.

Main results: Two randomized trials evaluated intraventricular streptokinase in infants developing post-hemorrhagic ventricular dilatation were identified When intraventricular streptokinase was compared with conservative management of post-hemorrhagic ventricular dilatation, the numbers of deaths and babies with shunt dependence were similar in both groups. No information on the effect of intraventricular streptokinase on disability is available. There is cause for concern about meningitis and secondary intraventricular hemorrhage, but numbers are insufficient to quantify the risks.

Authors' conclusions: Intraventricular fibrinolytic therapy with streptokinase, given when post-hemorrhagic ventricular dilatation is established, cannot be recommended for neonates following IVH. A conservative approach with CSF drainage applied only to symptomatic raised intracranial pressure seems appropriate.

PubMed Disclaimer

Conflict of interest statement

None

Figures

1.1
1.1. Analysis
Comparison 1 Intraventricular streptokinase vs control, Outcome 1 Hydrocephalus shunt.
1.2
1.2. Analysis
Comparison 1 Intraventricular streptokinase vs control, Outcome 2 Death.
1.3
1.3. Analysis
Comparison 1 Intraventricular streptokinase vs control, Outcome 3 Meningitis.
1.4
1.4. Analysis
Comparison 1 Intraventricular streptokinase vs control, Outcome 4 Secondary IVH.
See this image and copyright information in PMC

Update of

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

References to studies included in this review

Luciano 1997 {published data only}
    1. Luciano R, Velardi F, Romagnoli C, Papacci P, Stefano V, Tortorolo G. Failure of fibrinolytic endoventricular treatment to prevent neonatal post‐haemorrhagic hydrocephalus. Child's Nervous System 1997;13:73‐6. - PubMed
Yapicioglu 2003 {published data only}
    1. Yapicioglu H, Narli N, Satar M, Soyupak S, Altunbasak S. Intraventricular streptokinase for the treatment of posthaemorrhagic hydrocephalus of preterm. Journal of Clinical Neuroscience 2003;10:297‐9. [MEDLINE: ] - PubMed

Additional references

Hansen a 1997
    1. Hansen A, Whitelaw A, Lapp C, Brugnara C. Cerebrospinal fluid plasminogen activator inhibitor‐1: a prognostic factor in posthaemorrhagic hydrocephalus. Acta Paediatrica 1997;86:995‐8. - PubMed
Hansen b 1997
    1. Hansen AR, Volpe JJ, Goumnerova LC, Madsen JR. Intraventricular urokinase for the treatment of posthemorrhagic hydrocephalus. Pediatric Neurology 1997;17:213‐7. - PubMed
Hill 1984
    1. Hill A, Shackleford GD, Volpe JJ. A potential mechanism of pathogenesis for early posthemorrhagic hydrocephalus in the premature newborn. Pediatrics 1984;73:19‐21. - PubMed
Hudgins 1994
    1. Hudgins RJ, Boydston WR, Hudgins PA, Adler SR. Treatment of intraventricular hemorrhage in the premature infant with urokinase. A preliminary study. Pediatric Neurosurgery 1994;20:190‐7. - PubMed
Hudgins 1997
    1. Hudgins RJ, Boydston WR, Hudgins PA, Morris R, Adler SM, Gilreath CL. Intrathecal urokinase as a treatment for intraventricular hemorrhage in the preterm infant. Pediatric Neurosurgery 1997;26:281‐7. [PMID 9485155] - PubMed
Levene 1981
    1. Levene MI. Measurement of the growth of the lateral ventricle in preterm infants with real time ultrasound. Archives of Disease in Childhood 1981;56:900‐4. - PMC - PubMed
Nowak 1999
    1. Nowak S, Rudeck M, Polis L. Intraventricular administration of human recombinant plasminogen activator for posthemorrhagic hydrocephalus of the newborn. Acta Paediatrica 1999;88:995‐8. - PubMed
PHVD Trial 1998
    1. International PHVD Drug Trial Group. International randomised controlled trial of acetazolamide and furosemide in posthaemorrhagic ventricular dilatation in infancy. Lancet 1998;352:433‐40. - PubMed
Punt 1995
    1. Punt J. Neurosurgical management of hydrocephalus. In: Levene MI, Lilford RJ editor(s). Fetal and Neonatal Neurology and Neurosurgery. Edinburgh: Churchill Livingstone, 1995:661‐6.
Shinnar 1985
    1. Shinnar S, Gammon K, Bergman EW, Epstein M, Freedom JM. Management of hydrocephalus in infancy: use of acetazolamide and furosemide to avoid cerebrospinal fluid shunts. Journal of Pediatrics 1985;107:31‐6. - PubMed
Whitelaw 1992
    1. Whitelaw A, Rivers R, Creighton L, Gaffney P. Low dose intraventricular fibrinolytic therapy to prevent posthaemorrhagic hydrocephalus. Archives of Disease in Childhood 1992;67:F12‐4. - PMC - PubMed
Whitelaw 1995
    1. Whitelaw A, Mowinckel M‐C, Abildgaard U. Low levels of plasminogen in cerebrospinal fluid after intraventricular haemorrhage: a limiting factor for clot lysis?. Acta Paediatrica 1995;84:933‐6. - PubMed
Whitelaw 1996
    1. Whitelaw A, Saliba E, Fellman V, Mowinckel M‐C, Acolet D, Marlow N. Phase 1 study of intraventricular recombinant tissue plasminogen activator for treatment of posthaemorrhagic hydrocephalus. Archives of Disease in Childhood 1996;74:F20‐6. - PMC - PubMed
Whitelaw 1999
    1. Whitelaw A, Christie S, Pople I. Transforming Growth Factor Beta‐1: A possible signal molecule for posthemorrhagic hydrocephalus. Pediatric Research 1999;46:576‐80. - PubMed

References to other published versions of this review

Whitelaw 2000
    1. A Whitelaw. Intraventricular streptokinase after intraventricular hemorrhage in newborn infants. Cochrane Database of Systematic Reviews 2000, Issue 1. [DOI: 10.1002/14651858.CD000498] - DOI - PubMed
Whitelaw 2001
    1. A Whitelaw. Intraventricular streptokinase after intraventricular hemorrhage in newborn infants. Cochrane Database of Systematic Reviews 2001, Issue 1. [DOI: 10.1002/14651858.CD000498] - DOI - PubMed

MeSH terms

LinkOut - more resources